I have no doubt Merck is largely responsible for the fast track designation. There’s lots more to come from this partnership and the news will be good and frequent in biotech terms.
Well, if you ask me, this partnership with Merck is a one sided effort, Immutep doin the grunt, Merck providing
a bit of keytruda....
Myself, I think the fast track application was instigated by immutep and is a credit to them..
CHECKPOINT INHIBITORS - What The?, page-20
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.010(3.13%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.8¢ | 31.0¢ | $758.7K | 2.412M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 166349 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 312504 | 6 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |